Literature DB >> 27677683

Oral Surgical Treatment of Patients With Chronic Liver Disease: Assessments of Bleeding and Its Relationship With Thrombocytopenia and Blood Coagulation Parameters.

Nadia Cocero1, Marta Bezzi2, Silvia Martini3, Stefano Carossa4.   

Abstract

PURPOSE: Cirrhotic patients awaiting liver transplantation require eradication of infectious oral foci to prevent septic episodes after transplantation; however, cirrhosis can hinder hemostasis and can result in severe bleeding. The present study assessed the bleeding risk factors connected with the clinical history of these patients and the characteristics of the extractions.
MATERIALS AND METHODS: We retrospectively analyzed 1183 extractions in 318 patients, including 47 with severe end-stage liver disease who were outside of our intention-to-treat bracket (ie, platelet count [PLT] >40 × 103/μL and international normalized ratio [INR] <2.5). Follow-up examinations included inspection of the oral cavity on the first, third, and seventh days, with reparatory surgery in the case of severe bleeding. Continuous variables were compared using the Mann-Whitney U and Kruskal-Wallis tests, and categorical variables were compared using Fisher's exact test. Binary logistic regression analysis was also performed.
RESULTS: Within the intention-to-treat bracket, 1 of the 271 patients (0.4%) required surgical repair. The bleeding rate for an INR of 2.5 or more was significantly greater than that for a PLT of 40 × 103/μL or less (4 of 10 [40%] versus 2 of 34 [6%]; P = .02]. All 3 patients with both an INR of 2.5 or more and a PLT of 40 × 103/μL or less exhibited severe bleeding. No significant association between the occurrence of bleeding with either liver disease etiology or the number of molars extracted was found. No patient required hospitalization.
CONCLUSIONS: Patients with a PLT greater than 40 × 103/μL and an INR of less than 2.5 can be considered relatively low-risk patients. However, an INR of 2.5 or more and, to a minor degree, a PLT of 40 × 103/μL or less represent significant risk factors.
Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27677683     DOI: 10.1016/j.joms.2016.08.033

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  12 in total

1.  Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.

Authors:  Deirdre Mladsi; Christine Barnett; Kavita Aggarwal; Michael Vredenburg; Douglas Dieterich; Ray Kim
Journal:  Clinicoecon Outcomes Res       Date:  2020-09-14

2.  Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.

Authors:  Jonathan G Stine; Nicolas M Intagliata; Neeral L Shah; Ton Lisman; Francesco Violi; Stephen H Caldwell; Curtis K Argo
Journal:  Dig Dis Sci       Date:  2019-10-18       Impact factor: 3.199

3.  Prevalence of Panoramically Imaged Carotid Atheromas in Alcoholic Patients With Chronic Pancreatitis and Comorbid Diabetes.

Authors:  Urie K Lee; Tina I Chang; John C Polanco; Joseph R Pisegna; Arthur H Friedlander
Journal:  J Oral Maxillofac Surg       Date:  2018-05-15       Impact factor: 1.895

Review 4.  Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia.

Authors:  Domenico Alvaro; Nicola Caporaso; Edoardo Giovanni Giannini; Angelo Iacobellis; Mariacristina Morelli; Pierluigi Toniutto; Francesco Violi
Journal:  Eur J Clin Invest       Date:  2021-02-26       Impact factor: 4.686

5.  Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis.

Authors:  Jing Li; Bing Han; Hongyu Li; Han Deng; Nahum Méndez-Sánchez; Xiaozhong Guo; Xingshun Qi
Journal:  Saudi J Gastroenterol       Date:  2018 Jul-Aug       Impact factor: 2.485

6.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

Review 7.  Clinical Implications of Thrombocytopenia for the Cirrhotic Patient.

Authors:  Samuel H Sigal; Zachary Sherman; Arun Jesudian
Journal:  Hepat Med       Date:  2020-04-14

8.  Laser-assisted tooth extraction in patients with impaired hemostasis.

Authors:  Elena Vladimirovna Larionova; Ekaterina Yurievna Diachkova; Elena Anatolievna Morozova; Albert Artemovich Davtyan; Svetlana Viktorovna Tarasenko
Journal:  Biomedicine (Taipei)       Date:  2021-06-01

9.  The incidence of postoperative hemorrhage after tooth extraction in patients with thrombocytopenia.

Authors:  Sang-Hoon Kang; Min-Jun Kang
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2021-06-30

10.  Bleeding events in lusutrombopag-treated thrombocytopenic patients.

Authors:  Edoardo Giovanni Giannini; Takeshi Kano; Toshimitsu Ochiai; Roy Bentley; Pomy Shrestha; Nezam Afdhal
Journal:  Eur J Clin Invest       Date:  2021-02-12       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.